1,736
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Low-power bipolar radiofrequency ablation and vertebral augmentation for the palliative treatment of spinal malignancies

, , , , &
Pages 1282-1288 | Received 04 Dec 2017, Accepted 26 Dec 2017, Published online: 18 Jan 2018

References

  • Delank KS, Wendtner C, Eich HT, et al. (2011). The treatment of spinal metastases. Dtsch Arztebl Int 108:71–80.
  • Sutcliffe P, Connock M, Shyangdan D, et al. (2013). A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression. Health Technol Assess 17:1–274.
  • Harel R, Angelov L. (2010). Spine metastases: current treatments and future directions. Eur J Cancer 46:2696–707.
  • Hara S. (2008). Opioids for metastatic bone pain. Oncology 74 Suppl 1:52–4.
  • Lutz S, Balboni T, Jones J, et al. (2017). Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol 7:4–12.
  • Steenland E, Leer JW, van Houwelingen H, et al. (1999). The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52:101–9.
  • Dupuy DE, Liu D, Hartfeil D, et al. (2010). Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer 116:989–97.
  • Callstrom MR, Dupuy DE, Solomon SB, et al. (2013). Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 119:1033–41.
  • Bagla S, Sayed D, Smirniotopoulos J, et al. (2016). Multicenter prospective clinical series evaluating radiofrequency ablation in the treatment of painful spine metastases. Cardiovasc Intervent Radiol 39:1289–97.
  • Wallace AN, Greenwood TJ, Jennings JW. (2015). Radiofrequency ablation and vertebral augmentation for palliation of painful spinal metastases. J Neurooncol 124:111–18.
  • Wallace AN, Hillen TJ, Friedman MV, et al. (2017). Percutaneous spinal ablation in a sheep model: protective capacity of an intact cortex, correlation of ablation parameters with ablation zone size, and correlation of postablation MRI and pathologic findings. Am J Neuroradiol 38:1653.
  • Filippiadis DK, Binkert C, Pellerin O, et al. (2017). Cirse quality assurance document and standards for classification of complications: the Cirse Classification System. Cardiovasc Interv Radiol 40:1141–6.
  • Cazzato RL, Garnon J, Ramamurthy N, et al. (2016). Percutaneous management of accidentally retained foreign bodies during image-guided non-vascular procedures: novel technique using a large-bore biopsy system. Cardiovasc Interv Radiol 39:1050–6.
  • David E, Kaduri S, Yee A, et al. (2017). Initial single center experience: radiofrequency ablation assisted vertebroplasty and osteoplasty using a bipolar device in the palliation of bone metastases. Ann Palliat Med 6:118–24.
  • Hillen TJ, Anchala P, Friedman MV, Jennings JW. (2014). Treatment of metastatic posterior vertebral body osseous tumors by using a targeted bipolar radiofrequency ablation device: technical note. Radiology 273:261–7.
  • Tsoumakidou G, Too CW, Koch G, et al. (2017). CIRSE guidelines on percutaneous vertebral augmentation. Cardiovasc Interv Radiol 40:331–42.
  • Gangi A, Tsoumakidou G, Buy X, Quoix E. (2010). Quality improvement guidelines for bone tumour management. Cardiovasc Intervent Radiol 33:706–13.
  • Greenwood TJ, Wallace A, Friedman MV, et al. (2015). Combined ablation and radiation therapy of spinal metastases: a novel multimodality treatment approach. Pain Physician 18:573–81.
  • Di Staso M, Zugaro L, Gravina GL, et al. (2011). A feasibility study of percutaneous Radiofrequency Ablation followed by Radiotherapy in the management of painful osteolytic bone metastases. Eur Radiol 21:2004–10.
  • Di Staso M, Gravina GL, Zugaro L, et al. (2015). Treatment of solitary painful osseous metastases with radiotherapy, cryoablation or combined therapy: propensity matching analysis in 175 patients. PLoS One 10:e0129021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.